查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
糖尿病足潰瘍治療市場 - 全球行業規模、份額、趨勢、機會和預測，2018-2028 年：按治療、按潰瘍類型、按最終用戶、按地區細分、競爭
市場調查報告書
商品編碼
1255237

糖尿病足潰瘍治療市場 - 全球行業規模、份額、趨勢、機會和預測，2018-2028 年：按治療、按潰瘍類型、按最終用戶、按地區細分、競爭

Diabetic Foot Ulcer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Treatment, By Ulcer Type, By End User, By Region, and Competition
出版日期: | 出版商: TechSci Research | 英文 119 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球糖尿病足潰瘍治療市場預計在預測期內將出現顯著增長。

除了不健康的飲食習慣外，越來越多的人過著久坐不動的生活方式。 此外，對無痛和低成本治療的需求不斷增加，加上審美觀的提高，大大增加了世界各個地區對糖尿病足潰瘍治療的需求。 此外，世界各地日益老齡化的人口容易患足部潰瘍等各種類型的潰瘍病，這將進一步增加對各種牙齒輪廓的需求，推動市場增長到 2028 年。預計。 此外，由於全球不健康的生活方式導致肥胖症日益流行，預計在預測期內將進一步支持糖尿病足潰瘍治療市場。 此外，合適的醫療器械和藥品的使用率增加預計將增加對糖尿病足潰瘍治療的需求，這將推動市場的增長。 根據美國疾病控制和預防中心 (CDC) 的數據，美國 600 萬 18 歲及以上的人患有糖尿病前期，2640 萬 65 歲及以上的人 (48.8%) 患有糖尿病前期。

糖尿病足潰瘍患病率上升

快速增長的老年人口更容易患上各種類型的潰瘍等慢性病。 這一因素有望在未來幾年推動糖尿病足潰瘍治療市場。 由於外周血管疾病、葡萄糖相關疾病和其他慢性病的患病率增加，醫院獲得性壓力性潰瘍的風險增加，預計將在預測期內推動該行業的發展。 發達國家和發展中國家肥胖和外周動脈疾病的不斷增加降低了運動能力並增加了患慢性潰瘍的風險。 同樣，由於垃圾食品和飲酒而導致不健康的生活方式會導致人們患上肥胖症和糖尿病，進而造成更多的潰瘍，從而推動預測期內市場的增長。 2019 年，3730 萬美國人（佔人口的 11.3%）患有糖尿病。 約有 190 萬美國人患有 1 型糖尿病，其中包括約 244,000 名兒童和青少年。 由於發展中地區老齡化社會中 1 型糖尿病和成熟期糖尿病發病率的增加，糖尿病足潰瘍變得越來越普遍，這將進一步推動預測期內的市場增長。

技術進步

政府機構在研發領域不斷增加的投資和舉措是推動全球市場發展的關鍵因素。 糖尿病足潰瘍新療法的不斷發展和進步預計將在預測期內產生顯著增長。 例如，2019 年 7 月，全球再生醫學公司 AVITA Medical 宣布其用於治療糖尿病足潰瘍的 RECELL 自體細胞採集裝置的開放標籤可行性研究取得積極成果。 隨著醫院設施的可用性，越來越多的人選擇治療糖尿病足潰瘍。 高級傷口護理正在蓬勃發展，並將進一步吸引新進入者進入該市場。 新生物製劑的開發、技術創新以及皮膚移植的研發有望在未來幾年進一步推動市場增長。

近期發展

  • 2019年1月，UPM在歐洲市場推出了一款全新的先進傷口護理產品FibDex，這是一種由木基納米原纖維纖維素製成的傷口敷料，已獲得監管機構批准。已獲得 CE 標誌。

可定制產品

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析。

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢

第 4 章 VOC（客戶之聲）

第 5 章糖尿病足潰瘍的全球市場展望

  • 市場規模和預測
    • 按數量
  • 市場份額和預測
    • 按治療劑（傷口敷料、生物製劑、治療設備、抗生素等）
    • 按潰瘍類型（神經性潰瘍、缺血性潰瘍、神經源性缺血性潰瘍）
    • 按最終用戶（醫院/診所、門診診所、其他）
    • 按地區
    • 按公司分類（2022 年）
  • 市場地圖
    • 按治療方法
    • 按潰瘍類型
    • 最終用戶
    • 按地區

第 6 章北美糖尿病足潰瘍治療市場展望

  • 市場規模和預測
    • 按數量
  • 市場份額和預測
    • 按治療方法
    • 按潰瘍類型
    • 最終用戶
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲糖尿病足潰瘍治療市場前景

  • 市場規模和預測
    • 按數量
  • 市場份額和預測
    • 按治療方法
    • 按潰瘍類型
    • 最終用戶
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第 8 章亞太地區糖尿病足潰瘍治療市場展望

  • 市場規模和預測
    • 按數量
  • 市場份額和預測
    • 按治療方法
    • 按潰瘍類型
    • 最終用戶
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章南美糖尿病足潰瘍治療市場展望

  • 市場規模和預測
    • 按數量
  • 市場份額和預測
    • 按治療方法
    • 按潰瘍類型
    • 最終用戶
    • 按國家
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章中東和非洲糖尿病足潰瘍藥物市場展望

  • 市場規模和預測
    • 按數量
  • 市場份額和預測
    • 按治療方法
    • 按潰瘍類型
    • 最終用戶
    • 按國家
  • MEA：國家分析
    • 南非糖尿病足潰瘍藥物
    • 沙特阿拉伯糖尿病足潰瘍藥物
    • 阿聯酋糖尿病足潰瘍藥物
    • Turkiye 糖尿病足潰瘍治療
    • 埃及糖尿病足潰瘍藥物

第 11 章市場動態

  • 司機
  • 任務

第12章市場趨勢與發展

  • 近期趨勢
  • M&A（併購）
  • 產品發布

第13章競爭格局

  • 3M Company
  • Medtronic Plc
  • ConvaTec, Inc.
  • Coloplast Corporation
  • Smith & Nephew Plc
  • B Braun Melsungen AG
  • Medline Industries, Inc.
  • Organogenesis, Inc.
  • Molnlycke Health Care AB
  • Acelity L.P., Inc.

第 14 章戰略建議

簡介目錄
Product Code: 14342

The global diabetic foot ulcer treatment market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the increasingly leading sedentary lifestyle along with consuming unhealthy food habits. Additionally, the growing demand for painless Treatment with low cost coupled with increasing aesthetic consciousness among the population has significantly increased the demand for diabetic foot ulcer treatment across different parts of the globe. Additionally, the growing aging population across the globe, which is susceptible to different kinds of ulcer diseases like foot ulcers, is further expected to increase the demand for different dental contouring procedures, thereby fuelling the market growth through 2028. Besides, the growing prevalence of obesity because of leading unhealthy lifestyles across the globe is further expected to support the diabetic foot ulcer treatment market during the forecast period. Furthermore, the growing usage of proper medical equipment and medicines is further expected to increase the demand for diabetic foot ulcer treatment, thereby supporting market growth. According to the Centers for Disease Control and Prevention (CDC), 6 million people aged 18 years or older have prediabetes in the United States, and 26.4 million people aged 65 years or older (48.8%) have prediabetes.

Growing Prevalence of Diabetic Foot Ulcer

The rapidly increasing geriatric population is highly susceptible to chronic diseases such as different types of ulcers. This factor is expected to propel the diabetic foot ulcer treatment market in the next few years. An increase in the prevalence of peripheral vascular as well as sugar-related diseases and other chronic diseases leading to a rising risk of hospital-acquired pressure ulcers is expected to drive the segment during the forecast period. Constantly increasing obesity and peripheral artery diseases among developed and developing countries lead to decreased mobility and increased risk of acquiring chronic ulcers. Similarly, leading unhealthy lifestyles due to consuming junk food and alcohol, people are affected with obesity and diabetes, which will further create ulcers and enhance the growth of the market during the forecast period. In 2019, 37.3 million Americans, or 11.3% of the population, had diabetes. Nearly 1.9 million Americans have type 1 diabetes, including about 244,000 children and adolescents. Diabetic foot ulcers are more common because of the growing incidence in both types of I and maturity-onset diabetes among the aging population in the developing region, which will further propel the growth of the market during the forecast period.

Technological Advancement

Increasing investment and initiative by a government organization for research and development sectors is a major factor driving the market across the globe. An increase in the development of new treatments and advancement in diabetic foot ulcers is expected to create significant growth in the forecast period. For instance, in July 2019, AVITA Medical, g global regenerative medicine company, announced favorable results from an open-label feasibility study of the RECELL Autologous Cell Harvesting Device for the Treatment of Diabetic Foot Ulcers. Increasingly better hospital facility boosts the number of people opting for diabetic foot ulcer treatment. Advanced wound care is rapidly growing, which will further attract new players to invest in this market. Growing development in new biologic products, innovation, and research in skin grafts will further drive the growth of the market over the years.

Market Segmentation

The global diabetic foot ulcer treatment market can be segmented by Treatment, ulcer treatment, End User, and by region. Based on Treatment, the market can be segmented into Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, and Others. Based on ulcer treatment, the market can be differentiated into Neuropathic Ulcers, Ischemic Ulcers, and Neuroischemic Ulcers. Based on End Users, the market can be grouped into Hospitals & Clinics, Ambulatory Care Centers, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global diabetic foot ulcer treatment market.

Recent Developments

  • In January 2019, UPM launched a new advanced wound care product in the European market, and FibDex is the product for wound dressing, created from wood-based nano fibrillar cellulose, to receive regulatory approval and to be awarded a CE mark.

Market Players

3M Company, Medtronic Plc, ConvaTec, Inc., Coloplast Corporation, Smith & Nephew Plc, B Braun Melsungen AG, Medline Industries, Inc., Organogenesis, Inc., Molnlycke Health Care AB, Acelity L.P., Inc. are some of the leading players operating in the Global Diabetic Foot Ulcer Treatment Market.

Report Scope

In this report, global diabetic foot ulcer treatment market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Diabetic Foot Ulcer Treatment Market, By Treatment:

  • Wound Care Dressings
  • Biologics
  • Therapy Devices
  • Antibiotic Medications
  • Others

Diabetic Foot Ulcer Treatment Market, By Ulcer Treatment:

  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuroischemic Ulcers

Diabetic Foot Ulcer Treatment Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Diabetic Foot Ulcer Treatment Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Diabetic Foot Ulcer Treatment Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diabetic Foot Ulcer Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Others)
    • 5.2.2. By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuroischemic Ulcers)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Treatment
    • 5.3.2. By Ulcer Type
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Diabetic Foot Ulcer Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Treatment
    • 6.2.2. By Ulcer Type
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Diabetic Foot Ulcer Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Treatment
        • 6.3.1.2.2. By Ulcer Type
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Diabetic Foot Ulcer Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Treatment
        • 6.3.2.2.2. By Ulcer Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Diabetic Foot Ulcer Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Treatment
        • 6.3.3.2.2. By Ulcer Type
        • 6.3.3.2.3. By End User

7. Europe Diabetic Foot Ulcer Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Treatment
    • 7.2.2. By Ulcer Type
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Diabetic Foot Ulcer Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Treatment
        • 7.3.1.2.2. By Ulcer Type
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Diabetic Foot Ulcer Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Treatment
        • 7.3.2.2.2. By Ulcer Type
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Diabetic Foot Ulcer Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Treatment
        • 7.3.3.2.2. By Ulcer Type
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Diabetic Foot Ulcer Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Treatment
        • 7.3.4.2.2. By Ulcer Type
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Diabetic Foot Ulcer Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Treatment
        • 7.3.5.2.2. By Ulcer Type
        • 7.3.5.2.3. By End User

8. Asia-Pacific Diabetic Foot Ulcer Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Treatment
    • 8.2.2. By Ulcer Type
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Diabetic Foot Ulcer Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Treatment
        • 8.3.1.2.2. By Ulcer Type
        • 8.3.1.2.3. By End User
    • 8.3.2. India Diabetic Foot Ulcer Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Treatment
        • 8.3.2.2.2. By Ulcer Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Diabetic Foot Ulcer Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Treatment
        • 8.3.3.2.2. By Ulcer Type
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Diabetic Foot Ulcer Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Treatment
        • 8.3.4.2.2. By Ulcer Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Diabetic Foot Ulcer Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Treatment
        • 8.3.5.2.2. By Ulcer Type
        • 8.3.5.2.3. By End User

9. South America Diabetic Foot Ulcer Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Treatment
    • 9.2.2. By Ulcer Type
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Diabetic Foot Ulcer Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Treatment
        • 9.3.1.2.2. By Ulcer Type
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Diabetic Foot Ulcer Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Treatment
        • 9.3.2.2.2. By Ulcer Type
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Diabetic Foot Ulcer Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Treatment
        • 9.3.3.2.2. By Ulcer Type
        • 9.3.3.2.3. By End User

10. Middle East and Africa Diabetic Foot Ulcer Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Treatment
    • 10.2.2. By Ulcer Type
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Diabetic Foot Ulcer Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Treatment
        • 10.3.1.2.2. By Ulcer Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Diabetic Foot Ulcer Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Treatment
        • 10.3.2.2.2. By Ulcer Type
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Diabetic Foot Ulcer Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Treatment
        • 10.3.3.2.2. By Ulcer Type
        • 10.3.3.2.3. By End User
    • 10.3.4. Turkey Diabetic Foot Ulcer Treatment Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Treatment
        • 10.3.4.2.2. By Ulcer Type
        • 10.3.4.2.3. By End User
    • 10.3.5. Egypt Diabetic Foot Ulcer Treatment Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Treatment
        • 10.3.5.2.2. By Ulcer Type
        • 10.3.5.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. 3M Company
    • 13.6.2. Medtronic Plc
    • 13.6.3. ConvaTec, Inc.
    • 13.6.4. Coloplast Corporation
    • 13.6.5. Smith & Nephew Plc
    • 13.6.6. B Braun Melsungen AG
    • 13.6.7. Medline Industries, Inc.
    • 13.6.8. Organogenesis, Inc.
    • 13.6.9. Molnlycke Health Care AB
    • 13.6.10. Acelity L.P., Inc.

14. Strategic Recommendations